Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (88)	1/8/2001 1:16:51 PM
From: tuck	Read Replies (2) \| Respond to of 598

Wilder, Tularik updates 2001 at RS conference: biz.yahoo.com Not sure if what Dr. Goeddel expects is what the Street was expecting, but from the reaction, I'd say it was looking for more. The Dr. expects $30 million in collaborative revenue and one new strategic collaboration. I was looking for two, I admit, with all these unpartnered programs showing preclinical promise. But if TLRK has the cash, it would do well to develop some of 'em further on its own, so maybe I should just be patient. Don't own it, but my Mom does, and my target is $25, assuming I have any cash left if/when it gets there. Cheers, Tuck